“Patients need to have a voice, and if someone is not paying attention to the developing science and the risk has not been properly outlined and they couldn’t make an informed decision, then there has to be accountability.”
This was partner Alicia Theuma speaking to The Daily Telegraph for a major investigation into the experiences of women who developed meningiomas after using the contraceptive injection Depo-Provera. Austen Hays is pursuing a group action on behalf of women who developed meningiomas after using Depo-Provera.
The article and video interview examine concerns about the potential risks associated with prolonged use of Depo-Provera’s active ingredient, medroxyprogesterone acetate (MPA), and hear from women who have undergone brain surgery and been left with life-changing health problems.
The women featured in the investigation describe the profound impact their diagnoses and treatment have had on their health, independence, careers and families. Their experiences underline why access to clear information about potential risks matters when people are making decisions about their health.